Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Golden Seeds is one of the largest and most active early-stage investment firms in the United States focused on women-led businesses. Since 2004/2005, it has invested over $185 million in more than 250 companies across sectors including technology, healthcare, consumer products/services, and biotech. The firm operates a nationwide angel network with eight chapters and members in 27 states. Its investments have helped portfolio companies raise over $2 billion in additional capital
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Golden Seeds.